Literature DB >> 2456256

Alteration of amino-terminal codons of human granulocyte-colony-stimulating factor increases expression levels and allows efficient processing by methionine aminopeptidase in Escherichia coli.

P E Devlin1, R J Drummond, P Toy, D F Mark, K W Watt, J J Devlin.   

Abstract

We have improved the expression of recombinant human granulocyte-colony-stimulating factor (G-CSF), produced by either pL or trpP expression vectors in Escherichia coli, by altering the sequence at the 5' end of the G-CSF-coding region. Initial attempts to express G-CSF resulted in neither detectable G-CSF mRNA nor protein in the trpP system, and only G-CSF mRNA was detectable in the pL system. We modified both expression vectors to decrease the G + C content of the 5' end of the coding region without altering the predicted amino acid sequence. This resulted in expression of detectable G-CSF mRNA and protein in both systems. Expression reached 17% and 6.5% of the total soluble cellular protein in the pL and trpP expression systems, respectively. The N-terminal sequence of the recombinant G-CSF from the pL system was Met-Thr-Pro-Leu-Gly-Pro-. G-CSF isolated from several human cell lines (including the LD-1 cell line reported here), does not have an N-terminal methionyl residue. Deletion of the threonine codon at the beginning of the coding region for the mature G-CSF resulted in efficient removal of the N-terminal methionine residue during expression in E. coli.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456256     DOI: 10.1016/0378-1119(88)90412-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; K Terasaka; T Yamada
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

2.  Expression of recombinant human mutant granulocyte colony stimulating factor (Nartograstim) in Escherichia coli.

Authors:  F R Gomes; A C Maluenda; J O Tápias; F L S Oliveira; L C Sá-Rocha; E Carvalho; P L Ho
Journal:  World J Microbiol Biotechnol       Date:  2012-05-01       Impact factor: 3.312

3.  Characterization of the receptor binding determinants of granulocyte colony stimulating factor.

Authors:  D C Young; H Zhan; Q L Cheng; J Hou; D J Matthews
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

Review 4.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09

5.  Process development for production of human granulocyte-colony stimulating factor by high cell density cultivation of recombinant Escherichia coli.

Authors:  Rasoul Khalilzadeh; Jafar Mohammadian-Mosaabadi; Ali Bahrami; Ahmad Nazak-Tabbar; Mohammad Ali Nasiri-Khalili; Alireza Amouheidari
Journal:  J Ind Microbiol Biotechnol       Date:  2008-08-06       Impact factor: 3.346

6.  Impact of dissolved oxygen concentration on some key parameters and production of rhG-CSF in batch fermentation.

Authors:  Dasari V Krishna Rao; Chatadi T Ramu; Joginapally V Rao; Mangamoori L Narasu; Adibhatla Kali S Bhujanga Rao
Journal:  J Ind Microbiol Biotechnol       Date:  2008-06-03       Impact factor: 3.346

7.  Optimization of the AT-content of codons immediately downstream of the initiation codon and evaluation of culture conditions for high-level expression of recombinant human G-CSF in Escherichia coli.

Authors:  Dasari V Krishna Rao; Joginapally V Rao; Mangamoori L Narasu; Adibhatla Kali S Bhujanga Rao
Journal:  Mol Biotechnol       Date:  2007-11-27       Impact factor: 2.695

8.  Human G-CSF synthesis using stress-responsive bacterial proteins.

Authors:  Jong-Am Song; Kyung-Yeon Han; Jin-Seung Park; Hyuk-Seong Seo; Keum-Young Ahn; Jeewon Lee
Journal:  FEMS Microbiol Lett       Date:  2009-05-05       Impact factor: 2.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.